2018 annual financial data
Viridian Therapeutics 2018 Operating margin
Direct answer
Operating margin was -394.51%.
Operating income was -33,084,000 USD and net income was -32,703,000 USD.
Operating cash flow was -26,844,000 USD.
Get free Viridian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 8,386,000 USD
- Operating income
- -33,084,000 USD
- Net income
- -32,703,000 USD
- Operating cash flow
- -26,844,000 USD